Myeloid Sarcoma: An Overview.
MR de Cap, W Chen - Seminars in Diagnostic Pathology, 2023 - Elsevier
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an
extramedullary tumor mass of myeloid blasts with or without maturation that effaces tissue …
extramedullary tumor mass of myeloid blasts with or without maturation that effaces tissue …
[HTML][HTML] Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia
H Zhou, F Wang, T Niu - Frontiers in Nutrition, 2022 - frontiersin.org
Background: Amino acid (AA) metabolism plays a crucial role in cancer. However, its role in
acute myeloid leukemia (AML) is still unavailable. We screened out AA metabolic genes …
acute myeloid leukemia (AML) is still unavailable. We screened out AA metabolic genes …
[HTML][HTML] Severe gastrointestinal toxicity following the use of gilteritinib: a case series and analysis of postmarketing surveillance data
L Gozzo, A Nardo, S Brancati, A Judica, A Duminuco… - Healthcare, 2023 - mdpi.com
Gilteritinib has been approved as monotherapy in adults with acute myeloid leukemia (AML)
FLT3 mutated with relapsed or refractory disease, in light of its advantages in terms of …
FLT3 mutated with relapsed or refractory disease, in light of its advantages in terms of …
Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia
C Hou, Y Chen, S Liu, Y Jiang, D Huang, S Chen - Hematology, 2024 - Taylor & Francis
Objective: Extramedullary relapse (EMR) is rare in acute promyelocytic leukemia (APL) and,
there is a lack of information on its management. Current practices for EMR in APL are …
there is a lack of information on its management. Current practices for EMR in APL are …
Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin α7β1 Defines non-Leukemic Stem Cells with Migratory Potential
Interactions with the bone marrow (BM) niche are crucial for promoting self-renewal and
survival of acute myeloid leukemia (AML) cells. Consequently, AML cells express a variety of …
survival of acute myeloid leukemia (AML) cells. Consequently, AML cells express a variety of …
High through-put screening studies of intercellular cell interactions for small cell clusters using a microfluidic device
X Yuan - 2023 - search.proquest.com
Two primary projects were completed in this work in biochemistry and physical chemistry,
where cell-cell interactions and liposome-encapsulated metal nanoparticles were …
where cell-cell interactions and liposome-encapsulated metal nanoparticles were …
[HTML][HTML] Regression of leukemia cutis with gilteritinib in a case of FLT3-positive acute myeloid leukemia
A Duminuco, F Di Raimondo, E Mauro… - Current Problems in …, 2022 - Elsevier
Acute myeloid leukemia is a hematological disease with a poor prognosis. Blast cells that
characterize the disease are generally present in the bone marrow, but they can sometimes …
characterize the disease are generally present in the bone marrow, but they can sometimes …
Gilteritinib が奏効した中枢神経浸潤を伴う急性骨髄性白血病
小山玄太郎， 川口岳晴， 佐藤匠， 濱田千洋， 原暁 - 臨床血液, 2024 - jstage.jst.go.jp
抄録 [症例] 69 歳女性.[主訴] 発熱, 咳嗽.[現病歴] 発熱, 咳嗽のため受診した前医で白血球増多を
指摘され, 精査目的に当院紹介となった.[経過] 骨髄検査の結果急性骨髄単球性白血病と診断した …
指摘され, 精査目的に当院紹介となった.[経過] 骨髄検査の結果急性骨髄単球性白血病と診断した …